Drug Patents owned by Nexus Pharms

1. Drug name - EMERPHED

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090278 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same May, 2040

(17 years from now)

US11241400 NEXUS PHARMS Compositions comprising ephedrine or an ephedrine salt and methods of making and using same May, 2040

(17 years from now)

Drugs and Companies using EPHEDRINE SULFATE ingredient

Treatment: Use of ephedrine sulfate for treating hypotension

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
50MG/10ML (5MG/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.